Search

Dural arteriovenous fistulas are rare cerebrovascular lesions arising from abnormal connections between an artery and a vein. Though rare, high-grade aggressive lesions can cause hemorrhagic events and non-hemorrhagic neurologic deficits if left untreated. Treatment options vary based on angioarchitecture, location, and patient characteristics and range from conservative observation to palliative treatment, radiosurgery, endovascular embolization, and open surgery. The main goal of treatment is to obliterate flow through the abnormal connection and prevent further arterial flow to the venous system., Competing Interests: Disclosure Dr P. Jabbour is a consultant for Medtronic, MicroVention, Balt, and Cerus Endovascular. Dr S.I. Tjoumakaris is a consultant for MicroVention. Dr M.R. Gooch is a consultant for Stryker. Dr K. El Naamani has no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article., (Copyright © 2024 Elsevier Inc. All rights reserved.)

After robotic systems were approved for peripheral vascular interventions, many centers adopted this technology in treating carotid diseases. Robotic systems provide several advantages by eliminating radiation exposure and decreasing the rate of musculoskeletal injuries among interventionalists. The main disadvantage this technology poses is the lack of haptic feedback. Based on the experience of our center and several others, robotic systems have proved to be efficient, feasible, and safe when treating carotid diseases. One of the main goals of robotic systems is their future potential in remotely treating stroke patients living in rural geographic areas., Competing Interests: Disclosure This research received no specific grant from any funding agency in public, commercial, or not-for-profit sectors., (Copyright © 2021 Elsevier Inc. All rights reserved.)